調査レポート | • レポートコード：QYR2104Z4822 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、予防用B型肝炎ウイルスワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎、肝硬変、肝細胞癌、肝不全）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・予防用B型肝炎ウイルスワクチンの市場動向 ・企業の競争状況、市場シェア ・予防用B型肝炎ウイルスワクチンの種類別市場規模（B型肝炎、肝硬変、肝細胞癌、肝不全） ・予防用B型肝炎ウイルスワクチンの用途別市場規模（病院、診療所） ・予防用B型肝炎ウイルスワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・予防用B型肝炎ウイルスワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・予防用B型肝炎ウイルスワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・予防用B型肝炎ウイルスワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・予防用B型肝炎ウイルスワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Sanofi Pasteur、Novartis、Pfizer、GlaxoSmithKline） ・結論 |
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.
The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth of prophylactic hepatitis B virus vaccines market.
Market Analysis and Insights: Global Prophylactic Hepatitis B Virus Vaccines Market
The global Prophylactic Hepatitis B Virus Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prophylactic Hepatitis B Virus Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prophylactic Hepatitis B Virus Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prophylactic Hepatitis B Virus Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prophylactic Hepatitis B Virus Vaccines market.
Global Prophylactic Hepatitis B Virus Vaccines Scope and Market Size
Prophylactic Hepatitis B Virus Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Hepatitis B Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hepatitis B
Liver Cirrhosis
Hepatocellular Carcinoma
Liver Failure
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatitis B
1.2.3 Liver Cirrhosis
1.2.4 Hepatocellular Carcinoma
1.2.5 Liver Failure
1.3 Market by Application
1.3.1 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Perspective (2016-2027)
2.2 Prophylactic Hepatitis B Virus Vaccines Growth Trends by Regions
2.2.1 Prophylactic Hepatitis B Virus Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prophylactic Hepatitis B Virus Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Prophylactic Hepatitis B Virus Vaccines Industry Dynamic
2.3.1 Prophylactic Hepatitis B Virus Vaccines Market Trends
2.3.2 Prophylactic Hepatitis B Virus Vaccines Market Drivers
2.3.3 Prophylactic Hepatitis B Virus Vaccines Market Challenges
2.3.4 Prophylactic Hepatitis B Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue
3.1.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue (2016-2021)
3.1.2 Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prophylactic Hepatitis B Virus Vaccines Revenue
3.4 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio
3.4.1 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prophylactic Hepatitis B Virus Vaccines Revenue in 2020
3.5 Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Area Served
3.6 Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
3.7 Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Type
4.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2022-2027)
5 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Application
5.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size (2016-2027)
6.2 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type
6.2.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021)
6.2.2 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027)
6.2.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2027)
6.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application
6.3.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021)
6.3.2 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027)
6.3.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2027)
6.4 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country
6.4.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021)
6.4.2 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size (2016-2027)
7.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type
7.2.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2027)
7.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application
7.3.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2027)
7.4 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country
7.4.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type
8.2.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application
8.3.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region
8.4.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size (2016-2027)
9.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type
9.2.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2027)
9.3 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application
9.3.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2027)
9.4 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country
9.4.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type
10.2.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application
10.3.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country
10.4.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Introduction
11.1.4 Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Details
11.2.2 Sanofi Pasteur Business Overview
11.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Introduction
11.2.4 Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
11.2.5 Sanofi Pasteur Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Introduction
11.3.4 Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Introduction
11.4.4 Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Introduction
11.5.4 GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatitis B
Table 3. Key Players of Liver Cirrhosis
Table 4. Key Players of Hepatocellular Carcinoma
Table 5. Key Players of Liver Failure
Table 6. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2016-2021)
Table 10. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2022-2027)
Table 12. Prophylactic Hepatitis B Virus Vaccines Market Trends
Table 13. Prophylactic Hepatitis B Virus Vaccines Market Drivers
Table 14. Prophylactic Hepatitis B Virus Vaccines Market Challenges
Table 15. Prophylactic Hepatitis B Virus Vaccines Market Restraints
Table 16. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players (2016-2021)
Table 18. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2020)
Table 19. Ranking of Global Top Prophylactic Hepatitis B Virus Vaccines Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
Table 23. Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2016-2021)
Table 27. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Prophylactic Hepatitis B Virus Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2016-2021)
Table 31. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Prophylactic Hepatitis B Virus Vaccines Product
Table 66. Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Sanofi Pasteur Company Details
Table 69. Sanofi Pasteur Business Overview
Table 70. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product
Table 71. Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021) & (US$ Million)
Table 72. Sanofi Pasteur Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Prophylactic Hepatitis B Virus Vaccines Product
Table 76. Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Prophylactic Hepatitis B Virus Vaccines Product
Table 81. Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product
Table 86. GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Hepatitis B Features
Figure 3. Liver Cirrhosis Features
Figure 4. Hepatocellular Carcinoma Features
Figure 5. Liver Failure Features
Figure 6. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Prophylactic Hepatitis B Virus Vaccines Report Years Considered
Figure 10. Global Prophylactic Hepatitis B Virus Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prophylactic Hepatitis B Virus Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions: 2020 VS 2027
Figure 13. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2022-2027)
Figure 14. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players in 2020
Figure 15. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue in 2020
Figure 17. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2016-2021)
Figure 18. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2022-2027)
Figure 19. North America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2016-2027)
Figure 21. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2016-2027)
Figure 22. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2016-2027)
Figure 23. United States Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2016-2027)
Figure 27. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2016-2027)
Figure 28. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2016-2027)
Figure 29. Germany Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2016-2027)
Figure 39. China Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2016-2027)
Figure 47. Latin America Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2016-2027)
Figure 48. Latin America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2016-2027)
Figure 49. Mexico Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2016-2027)
Figure 55. Turkey Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
Figure 59. Sanofi Pasteur Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界のB型肝炎ウイルス（HBV）市場規模・現状・予測（2021年-2027年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…- 世界のC型肝炎ウイルス（HCV）市場規模・現状・予測（2021年-2027年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- 世界のC型肝炎ウイルス検査市場規模・現状・予測（2021年-2027年） Hepatitis C virus (HCV) infection is detected with a blood test. Market Analysis and Insights: Global Hepatitis C Virus Testing Market The global Hepatitis C Virus Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With i…
- 世界のC型肝炎ウイルス（HCV）用抗ウイルス剤市場規模・現状・予測（2021年-2027年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- 世界のC型肝炎ウイルス（HCV）検査市場規模・現状・予測（2021年-2027年） Hepatitis C Virus (HCV) Testing is the procedure to test if the patient have the Hepatitis C Virus. Market Analysis and Insights: Global Hepatitis C Virus (HCV) Testing Market The global Hepatitis C Virus (HCV) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in …